Federal Register / Vol. 70, No.
25 / Tuesday, February 8, 2005 / Notices
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, Centers for AIDS Research
(CFAR).
Date: March 1, 2005
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Gaithersburg Marriott
Washingtonian Center, 9751 Washingtonian
Boulevard, Gaithersburg, MD 20878.
Contact Person: Brenda Lange-Gustafson,
PhD, Scientific Review Administrator,
NIAID, DEA, Scientific Review Program,
Room 2217, 6700–B Rockledge Drive, MSC–
7616, Bethesda, MD 20892–7616, 301–496–
2550, bgustafson@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: February 1, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–2339 Filed 2–7–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse
and Alcoholism; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Special
Emphasis Panel, SBIR Contract Reviews (3
applications).
Date: February 11, 2005.
Time: 10 a.m. to 12 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, Fishers
Building, 5635 Fishers Lane 3033, Bethesda,
MD 20892, (telephone conference call).
Contact Person: Jeffrey I. Toward, PhD.
Scientific Review Administrator, National
Institutes of Health, National Institute on
Alcohol Abuse and Alcoholism, Extramural
VerDate jul<14>2003 18:12 Feb 07, 2005 Jkt 205001
6713
Project Review Branch, OSA, 5635 Fishers
Lane, Bethesda, MD 20892–9304, (301) 435–
5337, jtoward@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Special
Emphasis Panel, ZAA1 CC (30).
Date: February 18, 2005.
Time: 10 a.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: Holiday Inn Chevy Chase, 5520
Wisconsin Avenue, Terrace Room, Chevy
Chase, MD 20815.
Contact Person: Mahadev Murthy, PhD,
Scientific Review Administrator, Extramural
Project Review Branch, Office of Scientific
Affairs, National Institute on Alcohol Abuse,
and Alcoholism, MSC 9304, Room 3037,
Bethesda, MD 20892– 9304, (301) 433–0800,
mmurthy@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271, Alcohol Research
Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 93.273, Alcohol Research Programs;
93.891, Alcohol Research Center Grants,
National Institutes of Health, HHS)
Dated: February 1, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–2340 Filed 2–7–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse
and Alcoholism; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
PO 00000 Frm 00102 Fmt 4703 Sfmt 4703 E:\FR\FM\08FEN1.SGM
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Initial
Review Group Clinical and Treatment
Subcommittee AA–3.
Date: February 17–18, 2005.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Holiday Inn Chevy Chase, 5520
Wisconsin Avenue, Terrace Room, Chevy
Chase, MD 20815.
Contact Person: Mahadev Murthy, MBA,
PhD, Scientific Review Administrator,
Extramural Project Review Branch, Office of
Scientific Affairs, National Institute on
Alcohol Abuse, and Alcoholism, MSC 9304,
Room 3037, Bethesda, MD 20892–9304, (301)
443–0800, mmurthy@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271, Alcohol Research
Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 93.273, Alcohol Research Programs,
93.891, Alcohol Research Center Grants,
National Institutes of Health, HHS)
Dated: February 1, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–2341 Filed 2–7–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel, Predoctoral Research Training Grant
in Biostatistics.
Date: March 4, 2005.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
08FEN1
 6714 Federal Register / Vol. 70, No. 25 / Tuesday, February 8, 2005 / Notices
Place: Four Points by Sheraton Bethesda,
8400 Wisconsin Avenue, Bethesda, MD
20814.
Contact Person: Carole H. Latker, PhD,
Scientific Review Administrator, Office of
Scientific Review, National Institute of
General Medical Sciences, National Institutes
of Health, Natcher Building, Room 3AN–18,
Bethesda, MD 20892, (301) 594–2848,
latkerc@nigms.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives, National
Institutes of Health, HHS)
Dated: February 1, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–2342 Filed 2–7–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Initial Review
Group, Biomedical Research and Research
Training Review Subcommittee A.
Date: March 3, 2005.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Four Points by Sheraton Bethesda,
8400 Wisconsin Avenue, Bethesda, MD
20814.
Contact Person: Carole H. Latker, PhD,
Scientific Review Administrator, Office of
Scientific Review, National Institute of
General Medical Sciences, National Institutes
of Health, Natcher Building, Room 3AN–18,
Bethesda, MD 20892, (3010 594–2848,
latkerc@nigms.nih.gov.
VerDate jul<14>2003 20:29 Feb 07, 2005 Jkt 205001
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives, National
Institutes of Health, HHS)
Dated: February 1, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–2343 Filed 2–7–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse,
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel, Centers
Review Meeting.
Date: February 14, 2005.
Time: 8:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Ritz-Carlton Hotel at Pentagon City,
1250 South Hayes Street, Arlington, VA
22202.
Contact Person: Rita Liu, PhD, Associate
Director, OEA, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 212, MSC 8401, 6101 Executive
Boulevard, Bethesda, MD 20892–8401, (301)
435–1388.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute on
Drug Abuse Initial Review Group,
Medication Development Research
Subcommittee.
Date: February 28, 2005.
Time: 8:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
PO 00000 Frm 00103 Fmt 4703 Sfmt 4703 E:\FR\FM\08FEN1.SGM
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Khursheed Asghar, PhD,
Chief, Basic Sciences Review Branch, Office
of Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, Room 220, MSC
8401, 6101 Executive Boulevard, Bethesda,
MD 20892–8401, (301) 433–2755.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel,
Medication Development Conflict.
Date: February 28, 2005.
Time: 4 p.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Rita Liu, PhD, Associate
Director, OEA, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 212, MSC 8401, 6101 Executive
Boulevard, Bethesda, MD 20892–8401, (301)
435–1388.
Name of Committee: National Institute on
Drug Abuse Initial Review Group, Health
Services Research Subcommittee.
Date: March 1–2, 2005.
Time: 8:304 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Mark R. Green, PhD, Chief,
CEASRB, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 220, MSC 8401, 6101 Executive
Boulevard, Bethesda, MD 20892–8401, (301)
435–1431.
Name of Committee: National Institute on
Drug Abuse Initial Review Group, Treatment
Research Subcommittee.
Date: March 1–2, 2005.
Time: 9 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Kesinee Nimit, MD, Health
Scientist Administrator, Office of Extramural
Affairs, National Institute on Drug Abuse,
NIH, DHHS, Room 220, MSC 8401, 6101
Executive Boulevard, Bethesda, MD 20892–
8401, (301) 435–1432.
Name of Committee: National Institute on
Drug Abuse Initial Review Group, Training
and Career Development Subcommittee.
Date: March 8–10, 2005.
Time: 9 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Eliane Lazar-Wesley, PhD,
Health Scientist Administrator, Office of
Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, 6101 Executive
Boulevard, Room 220, MSC 8401, Bethesda,
MD 20892–8401, (301) 451–4530.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.277, Drug Abuse Scientist
Development Award for Clinicians, Scientist
08FEN1